Idiopathic epiretinal membranes: Cell type, growth factor expression, and fluorescein angiographic and retinal photographic correlations

Canadian Journal of Ophthalmology

Volumn 38, Issue 6, 2003, Pages 457-463

  Mandelcorn, Efrem ^a   Khan, Yasser ^a   Javorska, Livia ^a   Cohen, Justine ^a   Howarth, David ^a   Mandelcorn, Mark ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Epiretinal membranes; Macular; Scar; Transforming growth factor; Vascular endothelial growth factor; Vitrectomy

Indexed keywords

ACTIN; CYTOKERATIN; DESMIN; FLUORESCEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN; VIMENTIN;

ARTICLE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIRETINAL MEMBRANE; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; MICROSCOPY; PROTEIN EXPRESSION; RETINA; RETINA MACULA LUTEA; RISK; SCAR; STATISTICAL SIGNIFICANCE;

EID: 0345686462     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1016/S0008-4182(03)80023-6     Document Type: Article

References (16)

1. Michels RG. Surgery of epiretinal membranes. Dev Ophthalmol 1981;2:175-84.
2. McLeod D, Hiscott PS, Grierson I. Age-related cellular proliferation at the vitreoretinal juncture. Eye 1987;1(pt 2):263-81.
3. Kono T, Kohno T, Inomata H. Epiretinal membrane formation. Light and electron microscopic study in an experimental rabbit model. Arch Ophthalmol 1995;113:359-63.
4. Hiscott PS, Grierson I, Hitchins CA, Rahi AH, McLeod D. Epiretinal membranes in vitro. Trans Ophthalmol Soc UK 1983;103(pt 1):89-102.
5. Rodrigues MM, Newsome DA, Machemer R. Further characterization of epiretinal membranes in human massive periretinal proliferation. Curr Eye Res 1981;1:311-5.
6. Behzadian MA, Wang XL, Shabrawey M, Caldwell RB. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-β. Glia 1998;24:216-25.
7. 1 on in vitro angiogenesis. Exp Cell Res 1993;204:356-63.
8. Rosai J. Special techniques in surgical pathology. In: Rosai J, Barwick KW, Ordonez NG, Brunning RD, Bilbao JM, Ang LC, et al. Ackerman's surgical pathology, 8th ed. St. Louis: Mosby; 1996. p. 34-45.
9. Hiscott PS, Unger WG, Grierson I, McLeod D. The role of inflammation in the development of epiretinal membranes. Curr Eye Res 1988;7:877-92.
10. Schlingermann RO, van Hinsbergh VWM. Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol 1987;81:501-12.
11. Mussener A, Funa K, Kleinau S, Klareskog L. Dynamic expression of transforming growth factor-betas (TGF-β) and their type I and type II receptors in the synovial tissue of arthritic rats. Clin Exp Immunol 1997;107:112-9.
12. Hui YN, Sorgente N, Ryan SJ. Ultrastructures of the glial epiretinal membrane induced by activated macrophages. Chin Med J 1992;105:577-81.
13. 1, TGF-β receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 2000;41:2336-42.
14. Chen YS, Hackett SF, Schoenfeld CL, Vinores MA, Vinores SA, Campochiaro PA. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br J Ophthalmol 1997;81:919-26.
15. Cui JZ, Kimura H, Spee C, Thumann G, Hinton DR, Ryan SJ. Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate. Graefes Arch Clin Exp Ophthalmol 2000;238:326-33.
16. Hofman P, Blaauwgeers HGT, Tolentino MJ, Adamis AP, Cardozo BJN, Vrensen GFJM, et al. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytic vesicular transport and not with formation of fenestrations. Curr Eye Res 2000;21:637-45.